These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28826591)

  • 1. Individualised adaptive radiotherapy in liver cancer.
    Das M
    Lancet Oncol; 2017 Sep; 18(9):e520. PubMed ID: 28826591
    [No Abstract]   [Full Text] [Related]  

  • 2. Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.
    Feng M; Suresh K; Schipper MJ; Bazzi L; Ben-Josef E; Matuszak MM; Parikh ND; Welling TH; Normolle D; Ten Haken RK; Lawrence TS
    JAMA Oncol; 2018 Jan; 4(1):40-47. PubMed ID: 28796864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Hong TS; Wo JY; Yeap BY; Ben-Josef E; McDonnell EI; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Goyal L; Murphy JE; Javle MM; Wolfgang JA; Drapek LC; Arellano RS; Mamon HJ; Mullen JT; Yoon SS; Tanabe KK; Ferrone CR; Ryan DP; DeLaney TF; Crane CH; Zhu AX
    J Clin Oncol; 2016 Feb; 34(5):460-8. PubMed ID: 26668346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.
    Hong TS; DeLaney TF; Mamon HJ; Willett CG; Yeap BY; Niemierko A; Wolfgang JA; Lu HM; Adams J; Weyman EA; Arellano RS; Blaszkowsky LS; Allen JN; Tanabe KK; Ryan DP; Zhu AX
    Pract Radiat Oncol; 2014; 4(5):316-322. PubMed ID: 25194100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
    Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
    Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.
    Niska JR; Keane FK; Wolfgang JA; Hahn PF; Wo JY; Zhu AX; Hong TS
    Pract Radiat Oncol; 2016; 6(1):e9-16. PubMed ID: 26598907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pretreatment cholinesterase level on survival of inoperable intrahepatic or hepatic-hilar carcinomas treated with three-dimensional conformal radiotherapy.
    Hamamoto Y; Niino K; Ishiyama H; Hosoya T
    Radiat Med; 2004; 22(5):316-23. PubMed ID: 15553012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for liver tumors: ready for inclusion in guidelines?
    Tanguturi SK; Wo JY; Zhu AX; Dawson LA; Hong TS
    Oncologist; 2014 Aug; 19(8):868-79. PubMed ID: 25001265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-guided radiation therapy for liver tumors: gastrointestinal histology matters.
    Katsoulakis E; Riaz N; Cannon DM; Goodman K; Spratt DE; Lovelock M; Yamada Y
    Am J Clin Oncol; 2014 Dec; 37(6):561-7. PubMed ID: 23466584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoepithelioma-Like Carcinoma in Liver.
    Labgaa I; Stueck A; Ward SC
    Am J Pathol; 2017 Jul; 187(7):1438-1444. PubMed ID: 28500863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TACE plus external beam radiotherapy in liver cancer.
    Das M
    Lancet Oncol; 2018 May; 19(5):e231. PubMed ID: 29576417
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton radiotherapy for primary liver cancers.
    Granovetter M
    Lancet Oncol; 2016 Feb; 17(2):e49. PubMed ID: 26723084
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
    Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laser-induced thermotherapy for palliative treatment of malignant liver tumors: results of a clinical study].
    Albrecht D; Germer C; Isbert C; Buhr HJ
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():136-8. PubMed ID: 9101813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Beam Therapy in Liver Malignancies.
    Siddiqui O; Pollock A; Samanta S; Kaiser A; Molitoris JK
    Curr Oncol Rep; 2020 Feb; 22(3):30. PubMed ID: 32108284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma.
    Lee IJ; Seong J; Koom WS; Kim YB; Jeon BC; Kim JH; Han KH
    Jpn J Clin Oncol; 2011 Jul; 41(7):882-9. PubMed ID: 21515609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations.
    Eccles CL; Haider EA; Haider MA; Fung S; Lockwood G; Dawson LA
    Acta Oncol; 2009; 48(7):1034-43. PubMed ID: 19634060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.